ClinicalTrials.Veeva

Menu

Transperineal Laser Ablation for Low- and Intermediate Risk Prostate Cancer: a Single Cohort Analysis

S

San Carlo di Nancy Hospital

Status

Enrolling

Conditions

Prostate Cancer

Treatments

Procedure: Soractelite Echolaser Transperineal focal laser ablation

Study type

Interventional

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

The goal of this prospective study is to test the efficacy of Echolaser transperineal focal therapy in patients with low- and intermediate risk prostate cancer. The main question it aims to answer are: 1. short and intermediate term oncological outcomes after laser focal therapy, 2. functional outcomes and quality of life after treatment. Participants affected by low risk prostate cancer will undergo trans perineal laser focal therapy. Multiparametric prostate MRI will be perform after 3 and 12 months for oncological control. Re-fusion biopsy will be perform after 12 months. Functional outcomes and quality of life will be assess at 3, 6 and 12 months.

Enrollment

20 estimated patients

Sex

Male

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with low- and intermediate risk prostate cancer classified as International Society for Urological Pathology, ISUP 1-2.

Exclusion criteria

  • patients diagnosed with urothelial cancer
  • contraindications for MRI
  • Multifocal prostate cancer

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

TPLA in patients with prostate cancer
Experimental group
Description:
Patients diagnosed with low- and intermediate risk unifocal prostate cancer undergo to focal laser ablation therapy.
Treatment:
Procedure: Soractelite Echolaser Transperineal focal laser ablation

Trial contacts and locations

1

Loading...

Central trial contact

Valerio Iacovelli, MD, PhD; Pierluigi Bove, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems